 molecular immunolog approach manag bladder cancer heterogen natur bladder cancer variou therapeut option avail manag diseas constant challeng clinician varieti new biolog approach pathophysiolog behavior tumor mean clinic level monoclon antibodi immedi applic diagnost prognost tool impact treatment patient bladder cancer